Education & Training
Transplant Nephrologist, Medical Director of Living Donor Evaluation and Follow-up
Dr. Lentine is a Professor of Medicine with tenure at Saint Louis University, with joint appointments to Internal Medicine/Nephrology Division and to the Saint Louis University Center for Outcomes Research (SLUCOR). A California native, Dr. Lentine earned her MD degree from Stanford University, and also completed an Internal Medicine residency, Nephrology fellowship, and master’s degree in Clinical Epidemiology at Stanford. Upon moving to St. Louis, Dr. Lentine received additional fellowship training focused in Transplant Epidemiology and Outcomes at Washington University, and earned a PhD from the Saint Louis University School of Public Health.
Dr. Lentine oversees the medical evaluation and follow-up of Living Kidney Donors at the Transplant Center. Her professional service activities include participation as regional representative and vice chair of the United Network for Organ Sharing (UNOS) Living Donor Committee, and as co-chair of an active Kidney Disease: Improving Global Outcomes (KDIGO) work group on Live Donor Evaluation and Care. She participated as writing group member on the consensus article “Living Kidney Donor Follow-up: State-of-the-Art and Future Directions, Conference Summary and Recommendations,” and as a work-group member at a recent American Society of Transplantation (AST) consensus conference on Best Practices in Live Kidney Donation. Along with authoring review articles and editorials related to live donor outcomes, she edits the Live Kidney Donation section at Current Transplantation Reports.
Dr. Lentine is also a clinical scientist whose work is grounded in novel application and integration of national registries, administrative claims data, and other electronic health information sources to address topics in transplant-related epidemiology, outcomes and policy. Underlying themes of her research include advancing understanding of:
Among >120 publications in Medline-referenced journals to date (January 2015), Dr. Lentine is the first author of a N Engl J Med article describing racial variation in medical outcomes after living donation, and senior author of a N Engl J Med article investigating the impact of living donation on subsequent pregnancies. She served as first author and co-chair of a Scientific Statement from the American Heart Association on pre-transplant cardiac disease evaluation and management.
Dr. Lentine’s research support has included the Clinical Scientist in Nephrology Award from the American Kidney Fund and an NIH/NIDDK K08 Career Development Award for the study of “Cardiovascular Risk Prediction after Kidney Transplantation.” She served as PI for a multi-institutional NIH American Recovery and Reinvestment Act Challenge Grant, “Reducing geographic disparity in transplant access: Clinical and economic impact.” She is subcontract PI for our institution's participation in funded NIH R01 grants related to “Long‐Term Health Outcomes After Live Kidney Donation in African Americans” and “Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity.”